Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

NCS News

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

Written By: Brendan Baugher, DO, MS; Alexander Lewis, DO

The optimal duration of antibiotic therapy for bloodstream infections remains uncertain. Prolonged courses of antibiotics may increase iatrogenic adverse effects, resistance, and costs, while shorter courses may increase the risk of treatment failure. The BALANCE trial aimed to determine whether...

Neurocritical care society

Neurocritical Care Insights And
Perspectives From Around the World

Join Our Mailing List

Leading Insights, Business of Neurocritical Care

Business of Neurocritical Care: Billing Under the Attending Physician or APP—Which One is Right For You?

Written By: Ryan Hakimi, DO, MS, NVS, RPNI, CPB, FNCS, FCCM, FAAN

Since January 2022, split-shared critical care billing has been allowed. Split-shared billing enables members of a group (for example, physicians and APPs in the same Neurocritical Care Division) to aggregate their critical care billing time during a calendar day and get reimbursed for the sum...

Leading Insights

When the Algorithm (And Education) Aren’t Enough: Clinical Judgment in the Neuro ICU

Written By: Jordan Yakoby, EdD, DNP, ACNP-BC, CCRN, CNE, FNYAM, FCCM, FNCS

In my view, modern healthcare is plagued by two critical issues: the excessive reverence of protocols at the expense of sound clinical judgment and a looming educational crisis. Algorithms, protocols, and checklists guide many aspects of care, especially in the care of patients suffering from...

Leading Insights, Pharmacy

A Shot in the Dark: Are Intrathecal Therapies Effective for NMDA Receptor Encephalitis?

Written By: Nicolas Chiriboga, MD; Jose Irazuzta, MD